What is the difference between phase 1, 2, and 3 trials for Lymphoma
Understanding Clinical Trial Phases for Lymphoma
Clinical trials are research studies that test new treatments in people. They're organized into phases, each with different goals and numbers of participants. Here's what each phase does:
Phase 1 Trials: Safety & Dosage
Phase 1 trials focus on safety first. Researchers are asking: "Is this treatment safe? What dose can patients tolerate?"
- Participants: Usually 20-100 people
- Goal: Find the highest dose patients can handle without serious side effects
- What happens: Patients receive increasing doses while doctors carefully monitor for toxicity (harmful effects)
- Timeline: Often takes 1-2 years
- For lymphoma: Phase 1 might test a new targeted therapy or immunotherapy to see if it's safe enough to study further
Phase 2 Trials: Effectiveness & Side Effects
Phase 2 trials ask: "Does this treatment actually work? How effective is it?"
- Participants: Usually 100-500 people
- Goal: Measure how well the treatment works (response rates) and continue monitoring safety
- What happens: Patients receive the dose determined to be safe in Phase 1, and doctors track whether their lymphoma shrinks or improves
- Timeline: Often takes 2-3 years
- For lymphoma: Researchers might measure how many patients achieve remission (cancer goes away) or how long they stay in remission
Phase 3 Trials: Comparison & Confirmation
Phase 3 trials ask: "Is this new treatment better than the current standard treatment?"
- Participants: Usually 1,000-5,000 people
- Goal: Compare the new treatment to the best existing treatment (or placebo) to prove it's more effective
- What happens: Patients are randomly assigned to either the new treatment or the standard treatment. Neither the patient nor doctor knows which group they're in (this is called "blinded")
- Timeline: Often takes 2-3 years or longer
- For lymphoma: This might compare a new CAR T-cell therapy to standard chemotherapy, or test whether adding a new drug to existing treatment improves survival
Why This Matters for Lymphoma Patients
According to the NCCN Guidelines for Patients: Marginal Zone Lymphomas, understanding your treatment options—including clinical trials—is an important part of making informed decisions about your care. The Lymphoma Research Foundation (mentioned in NCCN resources) can help you find clinical trials that might be appropriate for your specific type of lymphoma.
Key Differences at a Glance
| Aspect | Phase 1 | Phase 2 | Phase 3 | |--------|---------|---------|---------| | Main Question | Is it safe? | Does it work? | Is it better? | | Participants | 20-100 | 100-500 | 1,000-5,000 | | Focus | Safety & dosage | Effectiveness | Comparison to standard | | Risk Level | Higher (unknown drug) | Moderate | Lower (compared to known treatment) |
Questions to Ask Your Doctor About Trials
If your oncologist mentions a clinical trial for your lymphoma:
- What phase is this trial in, and what does that mean for me?
- How does the new treatment compare to my current standard treatment options?
- What are the potential benefits and risks specific to this trial?
- Can I stop the trial if I experience serious side effects?
- How will my progress be monitored during the trial?
You can search for lymphoma clinical trials at clinicaltrials.gov (mentioned in NCCN Guidelines resources), where you can filter by lymphoma type, location, and trial phase.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
Your next question, already answered
Tap to keep going. 2 free answers, then a free account.
Ask Navis about your case
That answer is general. Ask about your specific situation. Answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Sources & medical oversight
- Grounded in NCCN Guidelines for Patients (Lymphomas) — the same guidelines oncologists use.
- Built by OpenCancer’s team of physician-scientists and cancer survivors.
- Last updated May 15, 2026. Informational only — not a substitute for your oncology team.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Source Guidelines
NCCN Guidelines for Patients (Lymphomas) (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with clinical trials for Lymphoma patients
Have your records handy? Add them to a private case for a deeper, personalized read →
Expert Webinars on Lymphoma
More questions about Lymphoma
- What is the difference between somatic and germline mutations in Lymphoma
- What is the difference between early stage and metastatic Lymphoma
- What is the difference between cure, control, and comfort care for Lymphoma
- What should I consider when choosing between clinical trial and standard treatment for Lymphoma
- The difference between intensive and non-intensive treatment approaches for mantle cell lymphoma, and how that might...
- Are Lymphoma clinical trials free
- How do I decide between surgery and radiation for Lymphoma
- What happens if the clinical trial treatment for Lymphoma doesn't work